|
1
|
Perez-Moreno P, Brambilla E, Thomas R and
Soria JC: Squamous cell carcinoma of the lung: molecular subtypes
and therapeutic opportunities. Clin Cancer Res. 18:2443–2451. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo NL, Dowlati A, Raese RA, Dong C, Chen
G, Beer DG, Shaffer J, Singh S, Bokhary U, Liu L, et al: A
predictive 7-gene assay and prognostic protein biomarkers for
non-small cell lung cancer. EBioMedicine. 32:102–110. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan X, Shen H, Jiang H, Hu D, Wang J and
Wu X: YXQ-EQ induces apoptosis and inhibits signaling pathways
important for metastasis in non-small cell lung carcinoma cells.
Cell Physiol Biochem. 49:911–919. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu C, Li X, Zhang D, Xu B, Hu W, Zheng X,
Zhu D, Zhou Q, Jiang J and Wu C: IL-1beta-mediated up-regulation of
WT1D via miR-144-3p and their synergistic effect with
NF-kappaB/COX-2/HIF-1alpha pathway on cell proliferation in LUAD.
Cell Physiol Biochem. 48:2493–2502. 2018. View Article : Google Scholar
|
|
6
|
Lee B, Lee T, Lee SH, Choi YL and Han J:
Clinicopathologic characteristics of EGFR, KRAS, and ALK
alterations in 6,595 lung cancers. Oncotarget. 7:23874–23884.
2016.PubMed/NCBI
|
|
7
|
Hou Z, Xu C, Xie H, Xu H, Zhan P, Yu L and
Fang X: Long noncoding RNAs expression patterns associated with
chemo response to cisplatin based chemotherapy in lung squamous
cell carcinoma patients. PLoS One. 9:e1081332014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao J, Liu Y, Zhang W, Zhou Z, Wu J, Cui
P, Zhang Y and Huang G: Long non-coding RNA Linc00152 is involved
in cell cycle arrest, apoptosis, epithelial to mesenchymal
transition, cell migration and invasion in gastric cancer. Cell
Cycle. 14:3112–3123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fan CN, Ma L and Liu N: Systematic
analysis of lncRNA-miRNA-mRNA competing endogenous RNA network
identifies four-lncRNA signature as a prognostic biomarker for
breast cancer. J Transl Med. 16:2642018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang YK and Yu JC: Circulating microRNAs
and long non-coding RNAs in gastric cancer diagnosis: An update and
review. World J Gastroenterol. 21:9863–9886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Sehgal L, Jain N, Khashab T,
Mathur R and Samaniego F: LncRNA MALAT1 promotes development of
mantle cell lymphoma by associating with EZH2. J Transl Med.
14:3462016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong L, Ding H, Li Y, Xue D and Liu Y:
LncRNA TINCR is associated with clinical progression and serves as
tumor suppressive role in prostate cancer. Cancer Manag Res.
10:2799–2807. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang X, Qi M, Wu R, Liu A, Chen D, Tang
L, Chen J, Hu X, Li W, Zhan L, et al: Long non-coding RNA CUDR
promotes malignant phenotypes in pancreatic ductal adenocarcinoma
via activating AKT and ERK signaling pathways. Int J Oncol.
53:2671–2682. 2018.PubMed/NCBI
|
|
14
|
Cao W, Wu W, Shi F, Chen X, Wu L, Yang K,
Tian F, Zhu M, Chen G, Wang W, et al: Integrated analysis of long
noncoding RNA and coding RNA expression in esophageal squamous cell
carcinoma. Int J Genomics. 2013:4805342013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Su X, Li G and Liu W: The long noncoding
RNA cancer susceptibility candidate 9 promotes nasopharyngeal
carcinogenesis via stabilizing HIF1a. DNA Cell Biol. 36:394–400.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shang C, Sun L, Zhang J, Zhao B, Chen X,
Xu H and Huang B: Silence of cancer susceptibility candidate 9
inhibits gastric cancer and reverses chemoresistance. Oncotarget.
8:15393–15398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma P, Zhang M, Nie F, Huang Z, He J, Li W
and Han L: Transcriptome analysis of EGFR tyrosine kinase
inhibitors resistance associated long noncoding RNA in non-small
cell lung cancer. Biomed Pharmacother. 87:20–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou J, Xiao H, Yang X, Tian H, Xu Z,
Zhong Y, Ma L, Zhang W, Qiao G and Liang J: Long noncoding RNA
CASC9.5 promotes the proliferation and metastasis of lung
adenocarcinoma. Sci Rep. 8:372018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiong DD, Li ZY, Liang L, He RQ, Ma FC,
Luo DZ, Hu XH and Chen G: The lncRNA NEAT1 accelerates lung
adenocarcinoma deterioration and binds to mir-193a-3pas a
competitive endogenous RNA. Cell Physiol Biochem. 48:905–918. 2018.
View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
21
|
Tomczak K, Czerwinska P and Wiznerowicz M:
The Cancer Genome Atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19A:A68–A77. 2015.
|
|
22
|
Hutter C and Zenklusen JC: The Cancer
Genome Atlas: Creating lasting value beyond its data. Cell.
173:283–285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He RQ, Gao L, Ma J, Li ZY, Hu XH and Chen
G: Oncogenic role of miR-183-5p in lung adenocarcinoma: A
comprehensive study of qPCR, in vitro experiments and bioinformatic
analysis. Oncol Rep. 40:83–100. 2018.PubMed/NCBI
|
|
24
|
Dang Y, Luo D, Rong M and Chen G:
Underexpression of miR-34a in hepatocellular carcinoma and its
contribution towards enhancement of proliferating inhibitory
effects of agents targeting c-MET. PLoS One. 8:e610542013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rong M, Chen G and Dang Y: Increased
miR-221 expression in hepatocellular carcinoma tissues and its role
in enhancing cell growth and inhibiting apoptosis in vitro. BMC
Cancer. 13:212013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang S and He R: Synergistic effect of
MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.
BioMed Research International. 2014:3841212014.PubMed/NCBI
|
|
27
|
Dang YW, Zeng J, He RQ, Rong MH, Luo DZ
and Chen G: Effects of miR-152 on cell growth inhibition, motility
suppression and apoptosis induction in hepatocellular carcinoma
cells. Asian Pac J Cancer Prev. 15:4969–4976. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBio- Portal. Sci Signal. 6:pl 12013. View Article : Google Scholar
|
|
29
|
Ooi AT, Gower AC, Zhang KX, Vick JL, Hong
L, Nagao B, Wallace WD, Elashoff DA, Walser TC, Dubinett SM, et al:
Molecular profiling of premalignant lesions in lung squamous cell
carcinomas identifies mechanisms involved in stepwise
carcinogenesis. Cancer Prev Res (Phila). 7:487–495. 2014.
View Article : Google Scholar
|
|
30
|
Arima C, Kajino T, Tamada Y, Imoto S,
Shimada Y, Nakatochi M, Suzuki M, Isomura H, Yatabe Y, Yamaguchi T,
et al: Lung adenocarcinoma subtypes definable by lung
development-related miRNA expression profiles in association with
clinicopathologic features. Carcinogenesis. 35:2224–2231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X,
Meng H, Guan X, Yang K and Bai Y: Up-regulation of lncRNA CASC9
promotes esophageal squamous cell carcinoma growth by negatively
regulating PDCD4 expression through EZH2. Mol Cancer. 16:1502017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lankat-Buttgereit B and Göke R: The tumour
suppressor Pdcd4: Recent advances in the elucidation of function
and regulation. Biol Cell. 101:309–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Allgayer H: Pdcd4, a colon cancer
prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol.
73:185–191. 2010. View Article : Google Scholar
|
|
34
|
Hwang SK, Minai-Tehrani A, Lim HT, Shin
JY, An GH, Lee KH, Park KR, Kim YS, Beck GR Jr, Yang HS, et al:
Decreased level of PDCD4 (programmed cell death 4) protein
activated cell proliferation in the lung of A/J mouse. J Aerosol
Med Pulm Drug Deliv. 23:285–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kaneko S, Li G, Son J, Xu CF, Margueron R,
Neubert TA and Reinberg D: Phosphorylation of the PRC2 component
Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.
Genes Dev. 24:2615–2620. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang KC, Yang YW, Liu B, Sanyal A,
Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta
RA, et al: A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature. 472:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao GD, Liu XY, Lin Y, Liu HF and Zhang
GJ: LncRNA CASC9 promotes tumorigenesis by affecting EMT and
predicts poor prognosis in esophageal squamous cell cancer. Eur Rev
Med Pharmacol Sci. 22:422–429. 2018.PubMed/NCBI
|
|
38
|
Kostenko S, Dumitriu G and Moens U: Tumour
promoting and suppressing roles of the atypical MAP kinase
signalling pathway ERK3/4-MK5. J Mol Signal. 7:92012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu Y, Yang C, Yang S, Cheng F, Rao J and
Wang X: miR-665 promotes hepatocellular carcinoma cell migration,
invasion, and proliferation by decreasing Hippo signaling through
targeting PTPRB. Cell Death Dis. 9:9542018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang J, Sun D, Wang Y, Ren F, Pang S, Wang
D and Xu S: FOSL2 positively regulates TGF-ß1 signalling in
non-small cell lung cancer. PLoS One. 9:e1121502014. View Article : Google Scholar
|
|
41
|
Remmelink M, Mijatovic T, Gustin A,
Mathieu A, Rombaut K, Kiss R, Salmon I and Decaestecker C:
Identification by means of cDNA microarray analyses of gene
expression modifications in squamous non-small cell lung cancers as
compared to normal bronchial epithelial tissue. Int J Oncol.
26:247–258. 2005.
|
|
42
|
Georgopoulos K: Ebf1 in DNA repair and
leukemogenesis. Blood. 125:3969–3971. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang J, Zhang J, Xu L, Zheng Y, Ling D and
Yang Z: Expression of HNF4G and its potential functions in lung
cancer. Oncotarget. 9:18018–18028. 2017.
|
|
44
|
Jiang B, Li Y, Qu X, Zhu H, Tan Y, Fan Q,
Jiang Y, Liao M and Wu X: Long noncoding RNA cancer susceptibility
candidate 9 promotes doxorubicin-resistant breast cancer by binding
to enhancer of zeste homolog 2. Int J Mol Med. 42:2801–2810.
2018.PubMed/NCBI
|
|
45
|
Klingenberg M, Groß M, Goyal A,
Polycarpou-Schwarz M, Miersch T, Ernst AS, Leupold J, Patil N,
Warnken U, Allgayer H, et al: The long noncoding RNA cancer
susceptibility 9 and RNA binding protein heterogeneous nuclear
ribonucleoprotein L form a complex and coregulate genes linked to
AKT signaling. Hepatology. 68:1817–1832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang
K, Guan X, Yang K and Bai Y: LncRNA CASC9 promotes esophageal
squamous cell carcinoma metastasis through upregulating LAMC2
expression by interacting with the CREB-binding protein. Cell Death
Differ. 25:1980–1995. 2018. View Article : Google Scholar : PubMed/NCBI
|
